Why did Gemini file for a crypto IPO now?
How does Trump-Musk feud affect Tesla’s stock?
What impact could Musk’s SpaceX threats have?
Why is Nvidia outperforming market expectations?
How will Trump’s tariffs affect retail profits?
What caused the latest US jobs report shift?
Why is Circle’s IPO shaking the crypto market?
Early Wins: RegenXBio's Gene Therapy Helps Duchenne Patients Walk Stronger, Longer
benzinga.com/markets/biotech/25/06/45797348/early-wins-regenxbios-gene-therapy-helps-duchenne-patients-walk-stronger-longer
RegenXBio Inc. (NASDAQ:RGNX) revealed new interim data on Thursday from the Phase 1/2 AFFINITY DUCHENNE trial.
Updates include positive functional, safety, and biomarker data for RGX-202, REGENXBIO’s investigational gene therapy for Duchenne muscular dystrophy.
The data update looked at…
This story appeared on benzinga.com, 2025-06-05 15:43:44.